Preliminary predictive criteria for COVID-19 cytokine storm
Open Access
- 25 September 2020
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 80 (1), 88-95
- https://doi.org/10.1136/annrheumdis-2020-218323
Abstract
Objectives To develop predictive criteria for COVID-19-associated cytokine storm (CS), a severe hyperimmune response that results in organ damage in some patients infected with COVID-19. We hypothesised that criteria for inflammation and cell death would predict this type of CS. Methods We analysed 513 hospitalised patients who were positive for COVID-19 reverse transcriptase PCR and for ground-glass opacity by chest high-resolution CT. To achieve an early diagnosis, we analysed the laboratory results of the first 7 days of hospitalisation. We implemented logistic regression and principal component analysis to determine the predictive criteria. We used a ‘genetic algorithm’ to derive the cut-offs for each laboratory result. We validated the criteria with a second cohort of 258 patients. Results We found that the criteria for macrophage activation syndrome, haemophagocytic lymphohistiocytosis and the HScore did not identify the COVID-19 cytokine storm (COVID-CS). We developed new predictive criteria, with sensitivity and specificity of 0.85 and 0.80, respectively, comprising three clusters of laboratory results that involve (1) inflammation, (2) cell death and tissue damage, and (3) prerenal electrolyte imbalance. The criteria identified patients with longer hospitalisation and increased mortality. These results highlight the relevance of hyperinflammation and tissue damage in the COVID-CS. Conclusions We propose new early predictive criteria to identify the CS occurring in patients with COVID-19. The criteria can be readily used in clinical practice to determine the need for an early therapeutic regimen, block the hyperimmune response and possibly decrease mortality.Keywords
Funding Information
- Lupus Research Alliance (The Role of Bacterial Infections in the Pathogenes)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R56 AR072115-01)
This publication has 43 references indexed in Scilit:
- Recommendations for the management of hemophagocytic lymphohistiocytosis in adultsBlood, 2019
- Programmed cell death as a defence against infectionNature Reviews Immunology, 2017
- Macrophage activation syndrome in the era of biologic therapyNature Reviews Rheumatology, 2016
- 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic ArthritisAnnals Of The Rheumatic Diseases, 2016
- Albumin rather than C-reactive protein may be valuable in predicting and monitoring the severity and course of acute respiratory distress syndrome in critically ill patients with or at risk for the syndrome after new onset feverBMC Pulmonary Medicine, 2015
- Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic SyndromeArthritis & Rheumatology, 2014
- GA: A Package for Genetic Algorithms inRJournal of Statistical Software, 2013
- Parallel Genetic AlgorithmsPublished by Springer Science and Business Media LLC ,2011
- The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritisRheumatic Disease Clinics of North America, 2004
- The CC chemokine CCL20 and its receptor CCR6Cytokine & Growth Factor Reviews, 2003